Light Mode
$0.0003 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0003, and at the day’s high of $0.0003
-0.05 (-99.46%) / 6M
Momentum, market sentiment, and recent alerts
BPTH reads n/a: price sits above one of the two key moving averages, the 12-month move is -99.7%.
No alerts for BPTH in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.